home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stem Cell Injections Improve Paralysis In Mouse Model Of Multiple Sclerosis

  April, 21 2003 7:20
your information resource in human molecular genetics
Injections of cultured adult brain stem cells help mice with a form of multiple sclerosis (MS) recover from paralysis, according to a paper in this week's Nature (pp. 688-694). Researchers hope that, in future, similar therapies will be used to treat human MS and other autoimmune diseases.

Gianvito Martino and Angelo Vescovi of the San Raffaele Hospital, Milan, Italy, and colleagues find that cultured adult brain stem cells injected into blood or spinal cord of mice suffering from an MS-like disease travel to areas of inflammation in the brain and spinal cord. There, they form new neurons and myelin-producing cells, decreasing the levels of inflammatory molecules and the amount of cellular scarring in the brain. Up to 30% of mice recover fully from their hind-leg paralysis, and the rest show a big improvement.

MS affects over one million people worldwide; there is currently no cure. "The potential of strategies such as this to treat neurological damage on a wide front is impressive," says Lawrence Steinman of Stanford University, California, in an accompanying News and View article.


Gianvito Martino tel +39 02 2643 4853
e-mail martino.gianvito@hsr.it

Angelo Vescovi tel +39 02 2156 0202
e-mail vescovi.angelo@hsr.it

Lawrence Steinman tel +1 650 725 6678
e-mail steinman@stanford.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.